Omega-3

We need to reframe the narrative from “avoid omega-6” to getting enough of the right omega-3s for long-term cardiometabolic and inflammatory health.

GC Rieber VivoMega introduced the ingredient Algae 1045 TG, a combination of DHA and EPA in triglyceride form, and will be present at Natural Products Expo West 2026 to highlight its omega-3 portfolio.

How do recent population and clinical studies link omega-3 blood levels—particularly DHA and EPA—to brain, cardiovascular, mental, reproductive, and exercise health, and what do these findings suggest about the value of biomarkers, disease risk reduction, and future research needs?

In this interview, Aleix Sala-Vila, PhD, explains results from a recently published longitudinal study linking omega-3 levels and risk of early-onset dementia.

In this interview, GC Rieber VivoMega discusses supply chain challenges, quality and regulatory standards, sustainability, and the growing role of algae-based omega-3s alongside traditional marine sources.

A large prospective UK Biobank study finds that higher blood omega-3 levels are associated with a significantly lower risk of dementia before age 65.

Explore our top four articles from 2025 on how diet and supplements enhance fertility, support women's health, and address unique wellness needs in the category's evolving landscape.

A retrospective analysis of data from the UK Biobank addressed conflicting reports and studies on the association between AF and fish oil supplements.

Specialty diets and nutritional supplements may help women physiologically prepare to pregnancy by improving the conditions for conception.

Analysis of 258,012 participants in the UK Biobank showed an inverse association between levels of omega-3s and risks for self-harm.

GC Rieber VivoMega announced that Thomas Helge Hansen has rejoined the company as the lead to their North American sales division.

Building muscle is important, but maintaining it is crucial as one ages. As a result, there is a growing demand for ingredients that help preserve muscle to help maintain an active lifestyle and quality of life.

The systematic review from AHRQ did not find a large body of evidence to suggest omega-3 intakes confer demonstrable advantages, and that there is too much heterogeneity and bias in the existing literature.

A six-week trial finds EPA and DHA Omega-3 supplements boost cardiac efficiency and lower heart rate compared to placebo in endurance-trained male amateur athletes.

Dietary fatty acids are highlighted as a potential intervention for the neurological disease.

The ODS recognizes DHA's role in reducing preterm birth risk, citing several studies and reports.

Epax has announced the launch of what they say is the first commercially available very long chain polyunsaturated fatty acid (VLC-PUFA), called Epax Evolve 05.

The Longevity Nutrient, published by Simon & Schuster, and written by Stephanie Venn-Watson, DVM, MPH is now available for purchase online and wherever books are sold.

The study examined various risk factors, such as blood pressure and diabetes, in predicting cardiovascular disease.

Women-led omega-3 research advances wellness for all women’s life stages.

The new technology, plus a new algal variation, will be introduced at Expo West 2025.

This study builds on previous animal research that found the lipid emulsion made from Ahiflower was associated with significantly lower inflammation, improved insulin sensitivity, and improved gut microbiota, compared to that of soybean oil or fish oil.

The study compared muscle recovery after injury in rats with and without fish oil supplementation in their diets.

Recent study evaluated the association between plasma omega-3 levels and risk of heart failure

The algal EPA+DHA ingredient expands on the company's existing algal omega-3 portfolio which was DHA only.